About CoVPN

We are dedicated to advancing research to find effective vaccines to prevent COVID-19

Over 700,000 Americans from all backgrounds volunteered with us to discover multiple vaccines during the pandemic and our work continues to protect vulnerable people.

Who We Are

The Coronavirus Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health to respond to the global pandemic.


HIV Vaccine Trials Network

The HIV Vaccine Trials Network (HVTN) is the world’s largest publicly funded international collaboration focused on the development of vaccines to prevent HIV/AIDS.

HIV Prevention Trials Network

The HIV Prevention Trials Network (HPTN) develops and tests the safety and efficacy of non-vaccine interventions designed to prevent the transmission of HIV.

Infectious Disease Clinical Research Consortium

NIAID established the Infectious Diseases Clinical Research Consortium in 2019. It encompasses the Institute’s long-standing Vaccine and Treatment Evaluation Units (VTEUs) and a new leadership group.

AIDS Clinical Trials Group

The ACTG established and supports the largest Network of expert clinical and translational investigators and therapeutic clinical trials units in the world. These investigators and units serve as the major resource for HIV/AIDS research on treatment and care for persons living with HIV/AIDS.